Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China

1.We investigated dyslipidemia in the top-ranked hospitals with relatively sufficient medical resources in China.2.The prevalence of dyslipidemia is high and the awareness, treatment, and control of dyslipidemia are relatively low in Chinese T2DM patients3.The situation of comprehensive management in T2DM is beyond optimism in China.